Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance | Zendy

Darrin J. Bast | Zendy; Abed Athamna | Zendy; Carla Duncan | Zendy; Joyce C. S. de Azavedo | Zendy; Donald E. Low | Zendy; Galia Rahav | Zendy; David J. Farrell | Zendy; Ethan Rubinstein | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance

Author(s) -

Darrin J. Bast,

Abed Athamna,

Carla Duncan,

Joyce C. S. de Azavedo,

Donald E. Low,

Galia Rahav,

David J. Farrell,

Ethan Rubinstein

Publication year - 2004

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkh294

Subject(s) - efflux , bacillus anthracis , ofloxacin , microbiology and biotechnology , broth microdilution , topoisomerase iv , dna gyrase , biology , quinolone , levofloxacin , gene , bacteria , antibiotics , genetics , escherichia coli , ciprofloxacin , minimum inhibitory concentration

To identify and characterize the mechanisms of high-level fluoroquinolone resistance in two strains of Bacillus anthracis following serial passage in increasing concentrations of fluoroquinolones.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research